IMMUNICON CORPORATION (NASD: IMMC)
"Up 36.49% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/IMMC.php

Immunicon Corporation and its subsidiaries engage in the development, manufacture, marketing, and sale of proprietary cell-based diagnostic and research products, and services with a focus on cancer. It develops technologies that identify, count, and characterize a small number of circulating tumor cells (CTC) and other rare cells present in a blood sample of a patient. The company offers CellSave Preservative tube, an evacuated blood collection tube with preservative; CellTracks AutoPrep system, an automated instrument to capture and label cells from 7.5 ml blood samples; CellTracks MagNest Cell Presentation device, a device that presents magnetically labeled cells for analysis; CellTracks Analyzer, a semi-automated fluorescence microscope used to count and characterize cells; and CellSearch Circulating Tumor Cell kit that is used for counting CTCs. It also offers CellSearch Profile kit, which is used to isolate CTCs for subsequent molecular or cellular analysis; CellTracks Endothelial Cell kit that is used in isolating and counting endothelial cells; CellTracks Bone Marrow Tumor kit, which is used to count tumor cells in a bone marrow sample; Tumor Profiling Reagents for CTC characterization; and CellTracks CEC Profile kit that is used to isolate CECs for molecular or cell analysis. The company sells its products to hospitals, reference laboratories, oncology practices, cancer treatment centers, clinical research organizations, and pharmaceutical/biotechnology companies in the United States, Europe, Japan, and Hong Kong. Immunicon has collaboration agreements with Veridex, LLC; Diagnostic HYBRIDS, Inc.; KREATECH Biotechnology B.V.; and University of Twente and STW. The company was founded in 1983 and is based in Huntingdon Valley, Pennsylvania.

IMMC News:

March 20 - Immunicon Appoints Teresa Lipcsey as its New Principal Accounting Officer

The Board of Directors of Immunicon Corporation (NASD: IMMC), a Delaware corporation, appointed Teresa O. Lipcsey as its new principal accounting officer, effective March 14, 2008. Ms. Lipcsey assumed the role of principal accounting officer from James G. Murphy, whose resignation as Immunicon's Senior Vice President, Finance and Administration and Chief Financial Officer was effective March 14, 2008.

Ms. Lipcsey, 42, has served as Vice President and Corporate Controller of Immunicon since January 2005. From December 2003 to January 2005, Ms. Lipcsey served as Executive Director and Controller of Immunicon. From May 1999 to December 2003, Ms. Lipcsey was Corporate Controller of Integrated Circuit Systems, Inc., a formerly public semiconductor company that designed, developed and marketed silicon timing devices. Ms. Lipcsey holds a B.S. in Accounting and Finance from University of Maryland and is a certified public accountant and a certified treasury professional.

Ms. Lipcsey's current annual salary is $200,000 and she is eligible to participate in the benefit plans generally offered to Immunicon officers and employees. In addition, Immunicon has agreed to provide Ms. Lipcsey with a severance package if she is terminated by Immunicon (and her performance prior to that termination is satisfactory) consisting of a lump sum payment equal to nine (9) months of her base salary and continuation of certain benefits under Immunicon's benefit plans for the one (1) month period following her termination. If Ms. Lipcsey agrees to sign a waiver at her termination under those circumstances, Immunicon has also agreed to continue certain benefits under Immunicon's benefit plans for a further two (2) month period in addition to the one (1) month period described above.

TRUSTCASH HOLDINGS (OTCBB: TCHH)
"Up 92.31% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/TCHH.php

Through its Trustcash brand and website (www.trustcash.com), the Company is a pioneer of anonymous payment systems for the Internet. It developed a business based on the sale of a stored value card (both virtual and physical) that can be used by consumers to make secure and anonymous purchases on the internet without disclosing their credit card or personal information. Trustcash provides to its customers the Trustcash™ payment card, which is sold in denominations ranging from $10 to $200 online through any of over 500 websites. Trustcash's non-reloadable, virtual Trustcash card is the only "stored value card" that can be purchased where no personal data is stored or available, providing a unique level of both security and privacy to the purchaser.

TCHH News:

March 14 - Trustcash Holdings, Inc. Releases the Third Segment of Its Chairman's Letter to Its Shareholders and Shareholders of Paivis, Corp.

"Merger and Integration to Produce a Solid Foundation for Generating Earnings"

Trustcash Holdings, Inc. (OTCBB: TCHH) ("TRUSTCASH") released the third segment of a letter from its Chairman, Dennis Shafer, to its shareholders and the shareholders of Paivis Corp. ("PAIVIS") (OTC: PAVC):

Dear Trustcash and Paivis Shareholders:

Recently Trustcash and Paivis announced a plan to commence working together for future integration purposes, etc. This forward thinking of both management teams shows a commitment to not only closing the merger but prepping for the building of a solid foundation to support growth towards the ultimate goal of generating earnings for our soon to be combined shareholder base.

The following provides more detail and insight into the opportunity before us in combining with Paivis and their pending acquisitions.

Operational Efficiencies:

The integration of four companies with a common market, similar transaction processing technology, and common administrative functions immediately creates an opportunity for cost reduction and improved cash flow through operational consolidation.

We believe a combined revenue base of $73 million can be generated with less than half the current operational expenses, potentially resulting in an immediate gain of 50% in net operating income.

Scale economies can also support enhanced customer service and competitive pricing...both key success factors in the debit card and phone card industries.

Technology Enhancements:

Combining the information systems technologies of four companies, all involved in high volume consumer payment transactions, provides an opportunity to develop a leading edge technology platform. This technology platform can be used to provide superior customer service, support new mobile and prepaid card applications, and provide an infrastructure for 'bolt-on' acquisitions of similar businesses in a fragmented market.

Expand Distribution:

All the products of the merged company can be sold through similar retail outlets. Consolidating sales and distribution efforts across potentially tens of thousands of retailers results in a national network of stored value cards available to a cash-based market. In addition, the power of the Trustcash web site (www.trustcash.com) can be used to generate additional traffic to these retail outlets.

Each merger partner can also distribute its products through all partners in the merger: Trustcash cards can be purchased through mobile cards owned by any Paivis phone card holder, and phone cards can be purchased using Trustcash virtual cash cards obtained through any Trustcash web site partner or retail location.

Build Brands:

The Trustcash brand is synonymous with security and privacy...both important benefits to a cash-based market, and a key competitive benefit in the phone card industry which has a history of consumer abuse. This brand can be used in conjunction with Paivis brands to create a greater market presence as well as cross-marketing each brand and its products to the other offerings. Joint POS marketing, media advertising, internet advertising, and word-of-mouth in a common market of immigrants and credit-restricted consumers will reinforce the impact of the merged company.

Expand Markets:

As a combined market and user base grows, the merged company will be in a position to rapidly expand its franchise to young adults and other cash-based consumer markets. In addition, a combined user base of over 100,000 consumers will further attract additional retailers, both physical and web based. The Trustcash web site will become a portal and a central location for a cash-based market to look for goods and services, while phone cards can be used to co-market all products and also to pay for Trustcash cards. This will ultimately provide an opportunity for the Trustcash card to expand to a multipurpose debit card for in-store purchases, and a general purpose gift card.

Acquisitions:

The stored value card market is very fragmented with some 2,000 different programs and providers. As Trustcash and its associated brands become the leader in the cash-based market, additional acquisitions will be targeted to expand the franchise into payroll cards, government payments, bill payments, money transfers, and other payment transactions.

Summary Facts:

* $100 billion plus e-Commerce market
* $171 billion closed-loop stored value card market
* $6 billion phone card market (according to an Atlantic-ACM report)
* Common cash-based market of 100 million consumers
* $73 million combined revenue
* 100,000 users
* Potential of over 70,000 retail outlets
* Common transaction processing and administrative functions
* Consolidated powerhouse in a fragmented market
* Integrating four of the leading growth industries: stored value
   cards, wireless services, Internet and e-Commerce, and cash-
   based payment transactions

In summary, we believe we are clearly headed towards a closing of a transaction that has the potential to be a major value provider for our shareholders.

Sincerely,

Dennis Shafer
Chairman
Trustcash Holdings, Inc.

ABOUT PAIVIS

Paivis Corp., a facility-based wholesale telecommunications carrier, delivers application/value-added services in the prepaid services market. It sells telecommunications products and services, such as prepaid calling cards, prepaid wireless service, and international wholesale terminations. The company also owns and operates a carrier-class prepaid calling platform, including 2 NACT phone card switches integrated with the voice over Internet protocol system dedicated to domestic and international termination and origination of calls. As of September 30, 2006, the company's products are sold through approximately 3,000 retail outlets in the United States. Paivis Corp. is headquartered in Atlanta, Georgia.

BLACKHAWK FUND (OTCBB: BHWF)
"Up 120.00% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/BHWF.php

The BlackHawk Fund operates as a business development company with interest in real estate development projects, as well as in media and television production in the United States. It redevelops and sells residential and commercial properties. The BlackHawk Fund owns, operates, manages, and implements proprietary media properties that primarily include network quality cable television shows, which are converted to online video magazines and DVDs. The company was founded in 1998 as USA Telecom. It changed its name to USA Telcom Internationale in 2000; to ZannWell, Inc. in 2004; and to The Blackhawk Fund in 2005. The company is based in Carson City, Nevada. The BlackHawk Fund is a subsidiary of Palomar Enterprises, Inc.

BHWF News:

March 20 - The Blackhawk Fund Update to Shareholders

The Blackhawk Fund (OTCBB: BHWF), has received correspondence from The Company's auditors that the 2007 10-KSB is complete and authorized to be filed after Thursday, March 20th.

On February 8th, The Blackhawk Fund announced an increase in revenue of 207% for fiscal year 2007, compared to the same period 2006. The increase in revenue has resulted from the implementation of The Company's media business, which commenced operations in January of last year. This increase will be reflected on the annual report being filed this week.

CAPITAL CORP OF THE WEST (NASD: CCOW)
"Up 72.34% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/CCOW.php

Capital Corp of the West, a bank holding company established November 1, 1995, is the parent company of County Bank, which has more than 30 years of service as "Central California's Community Bank." Currently, County Bank has forty-one branch offices serving thirteen counties in California. Its primary concentration is in the Central Valley of California. As of the latest FDIC data, County Bank has a 7.29% market share in the six Central California counties in which it has a significant retail branch presence, ranking County Bank fifth out of forty-one financial institutions in that market area. The company was founded in 1977 and is headquartered in Merced, California.

CCOW News:

March 20 - Capital Corp of the West Notes Potential for Strong First Quarter Capital Position

Capital Corp of the West (NASD: CCOW), the parent company of County Bank, has announced that, based on unaudited internal financial reports, its January and February 2008 month-end capital positions met or exceeded the regulatory definition of a well-capitalized financial institution. According to Don Briggs, chairman of the Regulatory Oversight Committee, “As of today we are well-capitalized.” Regulators define a well-capitalized institution as one that is above 10 percent in its risked-based capital ratio.

“We know that there have been questions in the marketplace and in the media about our 2007 earnings,” Mr. Briggs stated. “Like many other financial institutions in California’s Central Valley, the collapse of the real estate market significantly impacted our fourth quarter and our overall earnings for 2007. However, our performance in January and February 2008 has restored us to a well-capitalized position.”

County Bank customer deposits are insured by the FDIC to applicable limits and are backed by a bank with a solid community reputation that has been committed to serving its customers for more than 30 years. Briggs states, “County Bank looks forward to continuing its tradition of donating a portion of earnings each year in the 13 California counties it serves.”

CELL THERAPEUTICS (NASD: CTIC)
"Up 27.08% on Thursday "

Detailed Quote: http://www.otcpicks.com/quotes/CTIC.php

Cell Therapeutics, Inc. (CTI) markets lymphoma drug, Zevalin, in the United States. Zevalin is an FDA-approved radioimmunotherapeutic for treating lymphoma. The company also develops, acquires, and commercializes novel treatments for cancer. Its research and in-licensing activities are focused on identifying new, less toxic, and more effective ways to treat cancer. Cell Therapeutics is developing XYOTAX for the treatment of non-small cell lung cancer and ovarian cancer; Pixantrone, a novel compound in the class of drugs known as anthracyclines, for the treatment of non-Hodgkin's lymphoma; and Brostallicin, which is in first-line Phase II study for sarcoma. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd. and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.

CTIC News:

March 20 - Cell Therapeutics Approves Supplemental Cash Bonus for CEO James Bianco, Recommends Purchase of Company Stock

As part of its ongoing goal to encourage management to acquire and maintain increased levels of ownership of company stock and in recognition of his efforts with respect to recent debt and capital restructuring and the recent MAA filing for Xyotax in Europe, on March 20, 2008, the compensation committee of the board of directors of Cell Therapeutics, Inc. (NASD: CTIC), a Washington corporation, approved a supplemental cash bonus to James M. Bianco, M.D., the Company's President and CEO of $91,938, with an additional amount to cover the taxes on such award, with a recommendation to Dr. Bianco that the payment be used to purchase shares of company stock in the market.

SYNPLICITY INCORPORATED (NASD: SYNP)
"Up 1.14% on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/SYNP.php

Synplicity, Inc. provides software products that enable the design and verification of semiconductors used in networking and communications, semiconductor, military and aerospace, consumer, computer and peripherals, and other electronics systems. The company primarily offers programmable gate array (FPGA) and application specific integrated circuits (ASIC) solutions. Its products include Synplify and Synplify Pro, which are FPGA logic synthesis products; Synplify Premier, a solution that builds Synplicity's synthesis technology and adds new graph-based physical synthesis and real-time, simulator-like visibility into operating FPGA devices; Identify, a product that assists in debugging hardware directly in the register transfer level source code during chip operation; Synplify DSP product, which is used to bridge system level DSP design and analysis and semiconductor hardware design; and Certify, a software product for the verification of ASICs using prototypes consisting of multiple FPGAs. Synplicity, Inc. markets its products primarily in North America, Europe, and Japan and other Asian countries. The company was founded in 1994 and is based in Sunnyvale, California.

SYNP News:

March 20 - Synplicity Announces Acquisition By Synopsys

Synplicity, Inc. (NASD: SYNP), a leading supplier of solutions for the design and verification of semiconductors, today announced it has signed a definitive agreement to be acquired by Synopsys, Inc., (NASD: SNPS) a world leader in software and IP for semiconductor design and manufacturing. When completed, the acquisition will expand Synplicity’s product portfolio and extend the market reach of its industry leading products.

The combination of Synopsys’ world class simulation tools, virtual prototyping products, and IP with Synplicity’s Confirma platform, which accelerates functional verification of ASICs, will accelerate revenue growth in the rapidly growing market for SoC verification solutions. The acquisition also provides the opportunity to leverage Synopsys’ advanced IC technology to further improve Synplicity’s market leading FPGA synthesis products, and Synplicity will gain an expanded product portfolio with which to serve its approximately 1,800 customers.

Under the terms of the agreement, Synopsys will pay $8 cash per Synplicity share, resulting in a gross transaction value of approximately $227 million, and approximately $188 million net of cash acquired. The transaction is subject to regulatory and Synplicity shareholder approval, and other customary closing conditions, and is expected to close in the second calendar quarter of 2008. After the closing, Synplicity will become part of Synopsys, and Synplicity stock will cease trading.

“The acquisition by Synopsys will allow us to scale Synplicity’s FPGA and rapid prototyping business to help more designers successfully solve the increasingly complex problems associated with creating today’s chips and systems,” said Gary Meyers, president and CEO of Synplicity.

“Synplicity’s strong product portfolio, expertise, and customer reach will be ideal complements to Synopsys,” said Aart deGeus, chairman and CEO of Synopsys. “The combination will expand our presence in the systems and mid-tier market segments, will support our strategy to provide rapid prototyping capabilities to a broad set of customers to enable much faster software development, and will enhance Synplicity’s already strong offering in the FPGA implementation market.”

“Today’s pervasive use of FPGAs for system implementation and SoC verification is creating demand for more complete product solutions and expanded technology innovation. I look forward to meeting this innovation challenge with the combined technology assets, complementary talents and similar cultures of our two companies,” said Ken McElvain, co-Founder, chief technical officer and vice president of Synplicity.

Gary Meyers will join Synopsys as a general manager. Ken McElvain will join Synopsys to help architect the company’s systems solutions.

Deutsche Bank Securities Inc. acted as exclusive financial advisor to Synplicity.